Lokanatha Dasappa

Survival outcomes of the NeoALTTO study (BIG 1–06): updated results of a randomised multicenter phase III neoadjuvant clinical trial in patients with HER2-positive primary breast cancer

Jens Huober, Eileen Holmes, José Baselga et al. · European Journal of Cancer · 2019 · 90 citations · Full text

Medicine, Oncology, Breast Oncology +12

Bavituximab plus paclitaxel and carboplatin for the treatment of advanced non-small-cell lung cancer

Raghunadharao Digumarti, P. P. Bapsy, Attili Venkatasatya Suresh et al. · Lung Cancer · 2014 · 41 citations

Medicine, Oncology, Pharmacology +12

Epidemiology and outcomes of nasopharyngeal carcinoma: Experience from a regional cancer center in Southern India

Rudresha Antapura Haleshappa, Aditi Harsh Thanky, Lakshmaiah Chinnagiriyappa Kuntegowdanahalli et al. · South Asian Journal of Cancer · 2017 · 38 citations · Full text

Medicine, Oncology, Surgery +16

Prognostic and predictive implications of Sokal, Euro and EUTOS scores in chronic myeloid leukaemia in the imatinib era—experience from a tertiary oncology centre in Southern India

Lakshmaiah Chinnagiriyappa Kuntegowdanahalli, Govind Babu Kanakasetty, Aditi Harsh Thanky et al. · ecancermedicalscience · 2016 · 33 citations · Full text

Medicine, Hematology, Oncology +11

Rituximab biosimilar RTXM83 versus reference rituximab in combination with CHOP as first-line treatment for diffuse large B-cell lymphoma: a randomized, double-blind study

Myrna Candelaria, Derlis Gonzalez, Márcia Torresan Delamain et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2019 · 32 citations · Full text

Medicine, Pharmacology, Cancer Immunology +6